1. Academic Validation
  2. Identification of a novel human uridine phosphorylase

Identification of a novel human uridine phosphorylase

  • Biochem Biophys Res Commun. 2003 Jul 18;307(1):41-6. doi: 10.1016/s0006-291x(03)01062-3.
Magnus Johansson 1
Affiliations

Affiliation

  • 1 Division of Clinical Virology F68, Karolinska Institute, Huddinge University Hospital, Stockholm, S-14186, Sweden. magnus.johansson@mbb.ki.se
Abstract

Uridine phosphorylase catalyzes the reversible phosphorylytic cleavage of uridine and deoxyuridine to uracil and ribose- or deoxyribose-1-phosphate. The Enzyme has an important role in the metabolism of pyrimidine analogs used in Cancer chemotherapy. The cDNA of a novel 317 amino acid human uridine phosphorylase approximately 60% identical to the previously identified human uridine phosphorylase was cloned. The novel Enzyme, named uridine phosphorylase-2 (UPase-2), showed broad substrate specificity and accepted uridine, deoxyuridine, and thymidine as well as the two pyrimidine nucleoside analogs 5-fluorouridine and 5-fluoro-2(')-deoxyuridine. The human UPase-2 gene was mapped to chromosome 2q24.1 and the 2.2-kb mRNA was predominantly expressed in kidney. The mouse UPase-2 cDNA was also identified and shown to be predominantly expressed in liver. The identification of a novel uridine phosphorylase with broad substrate specificity is important for studies on both nucleoside metabolism as well as for studies on the pharmacological mechanisms of therapeutic pyrimidine nucleoside analogs.

Figures